Re: New Clinical Trials Alert/ NO RP related

[Guest guest]

In a message dated 5/28/02 6:05:08 AM Pacific Daylight Time,

information@... writes:

<<

Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic

Graft-Versus-Host Disease:

Birmingham, Alabama

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=1 & trial_id=NCT000

31824 & source_cd=NIH & camp=mlcttx

Tucson, Arizona

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=2 & trial_id=NCT000

31824 & source_cd=NIH & camp=mlcttx

Little Rock, Arkansas

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=3 & trial_id=NCT000

31824 & source_cd=NIH & camp=mlcttx

Duarte, California

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=4 & trial_id=NCT000

31824 & source_cd=NIH & camp=mlcttx

San Diego, California

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=6 & trial_id=NCT000

31824 & source_cd=NIH & camp=mlcttx

Oakland, California

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=8 & trial_id=NCT000

31824 & source_cd=NIH & camp=mlcttx

Orange, California

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=9 & trial_id=NCT000

31824 & source_cd=NIH & camp=mlcttx

Los Angeles, California (4 locations)

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=11 & trial_id=NCT00

031824 & source_cd=NIH & city=Los+Angeles & state=CA & camp=mlcttx

Downey, California

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=12 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Stanford, California

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=13 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

San Francisco, California

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=14 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Denver, Colorado (2 locations)

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=16 & trial_id=NCT00

031824 & source_cd=NIH & city=Denver & state=CO & camp=mlcttx

Washington, District of Columbia (2 locations)

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=18 & trial_id=NCT00

031824 & source_cd=NIH & city=Washington & state=DC & camp=mlcttx

Saint sburg, Florida

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=19 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Miami, Florida

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=20 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

ville, Florida

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=21 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Gainesville, Florida

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=22 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Atlanta, Georgia (2 locations)

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=24 & trial_id=NCT00

031824 & source_cd=NIH & city=Atlanta & state=GA & camp=mlcttx

Augusta, Georgia (2 locations)

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=26 & trial_id=NCT00

031824 & source_cd=NIH & city=Augusta & state=GA & camp=mlcttx

Honolulu, Hawaii

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=27 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Chicago, Illinois (2 locations)

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=29 & trial_id=NCT00

031824 & source_cd=NIH & city=Chicago & state=IL & camp=mlcttx

Indianapolis, Indiana

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=30 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Iowa City, Iowa

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=31 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Lexington, Kentucky

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=32 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Louisville, Kentucky

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=33 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

New Orleans, Louisiana

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=34 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Scarborough, Maine

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=35 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Baltimore, land

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=36 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Boston, Massachusetts (3 locations)

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=39 & trial_id=NCT00

031824 & source_cd=NIH & city=Boston & state=MA & camp=mlcttx

Detroit, Michigan

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=40 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Grand Rapids, Michigan

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=41 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Saint , Minnesota

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=44 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Rochester, Minnesota

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=45 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Minneapolis, Minnesota (3 locations)

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=46 & trial_id=NCT00

031824 & source_cd=NIH & city=Minneapolis & state=MN & camp=mlcttx

, Mississippi

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=47 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Kansas City, Missouri

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=49 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Saint Louis, Missouri (2 locations)

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=50 & trial_id=NCT00

031824 & source_cd=NIH & city=Saint+Louis & state=MO & camp=mlcttx

Omaha, Nebraska

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=51 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Hackensack, New Jersey

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=52 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Princeton, New Jersey

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=53 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Valhalla, New York

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=57 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

New York, New York (3 locations)

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=58 & trial_id=NCT00

031824 & source_cd=NIH & city=New+York & state=NY & camp=mlcttx

Buffalo, New York

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=59 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

New Hyde Park, New York (2 locations)

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=60 & trial_id=NCT00

031824 & source_cd=NIH & city=New+Hyde+Park & state=NY & camp=mlcttx

Syracuse, New York

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=61 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Rochester, New York

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=62 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Durham, North Carolina

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=63 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Chapel Hill, North Carolina

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=64 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Cincinnati, Ohio

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=65 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Columbus, Ohio

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=66 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Cleveland, Ohio (2 locations)

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=68 & trial_id=NCT00

031824 & source_cd=NIH & city=Cleveland & state=OH & camp=mlcttx

Oklahoma City, Oklahoma

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=69 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Portland, Oregon (2 locations)

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=71 & trial_id=NCT00

031824 & source_cd=NIH & city=Portland & state=OR & camp=mlcttx

Philadelphia, Pennsylvania

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=72 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Pittsburgh, Pennsylvania

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=73 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

ton, South Carolina

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=74 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Memphis, Tennessee

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=75 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Nashville, Tennessee

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=76 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Fort Worth, Texas

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=78 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Dallas, Texas

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=81 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Houston, Texas (2 locations)

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=82 & trial_id=NCT00

031824 & source_cd=NIH & city=Houston & state=TX & camp=mlcttx

San , Texas (3 locations)

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=83 & trial_id=NCT00

031824 & source_cd=NIH & city=San+ & state=TX & camp=mlcttx

Salt Lake City, Utah

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=84 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Falls Church, Virginia

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=85 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Richmond, Virginia

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=86 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Spokane, Washington

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=87 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Milwaukee, Wisconsin

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=88 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Madison, Wisconsin

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=89 & trial_id=NCT00

031824 & source_cd=NIH & camp=mlcttx

Study of Improving Pain Management in Patients With Non-Hematologic Cancer:

Newton Upper Falls, Massachusetts

http://www.acurian.com/patient/trial/trialdetail.jsp?site_id=1 & trial_id=NCT000

36829 & source_cd=NIH & camp=mlcttx

>>